Company Directory / Medical Device

O

PrivateFor profitMedical DeviceMontréal, QC, Canada

Optina Diagnostics

Optina Diagnostics develops technology for the early detection of disease through the eye.

Founded
2011
15 years ago
Staff
11-50
27 on LinkedIn
Followers
5k
on LinkedIn
Funding
$25M
as listed, USD

Optina Diagnostics is revolutionizing medical diagnostics with our Retinal Deep Phenotyping platform that brings clarity and accessibility to early-stage diagnosis of diseases of the eye, and so much more. Optina aims to improve the lives of older adults by making diagnosis and precision medicine a reality. We are addressing major challenges faced by healthcare systems that support aging populations. The Optina-4C hyperspectral camera for imaging the retina (back of the eye) is FDA-cleared and licensed by Health… Read all

Optina Diagnostics is revolutionizing medical diagnostics with our Retinal Deep Phenotyping platform that brings clarity and accessibility to early-stage diagnosis of diseases of the eye, and so much more. Optina aims to improve the lives of older adults by making diagnosis and precision medicine a reality. We are addressing major challenges faced by healthcare systems that support aging populations. The Optina-4C hyperspectral camera for imaging the retina (back of the eye) is FDA-cleared and licensed by Health Canada. It brings a new dimension to medical imaging - the power of the spectral (color) dimension - and reveals unprecedented information about cellular and molecular changes. Optina's Retinal Deep Phenotyping platform combines data-rich images from the Optina-4C camera with Artificial intelligence-driven algorithms to deliver automated, accessible, and equitable diagnostic information about eye diseases like Age-related Macular Degeneration, as well as systemic diseases like Alzheimer's and cardiac stenosis. Optina has been granted Breakthrough Device Designation by the FDA for our Alzheimer's test which enables a dramatic improvement in the differential diagnosis of dementia.

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed. 27 people list it on LinkedIn.

Age

201119002026

15 years old.

Reach

Website ranked #3,786,763 in the world for traffic, about 3k visits a month. 4,865 followers on LinkedIn.

What it does

BiotechnologyMedical DeviceAlzheimer's DiseaseRetinal ImagingMedical DevicesDiagnostic ImagingPhenotypingArtificial IntelligenceDiseases of the eye

Funding, as listed

$25M raised in total

  • Rounds5
  • LatestSeries a, Jan 2022
  • Latest amountUSD 2,100,000
  • Investors17, 4 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersChantal Miklosi, David Lapointe

Every detail we hold

Everything the source datasets list about Optina Diagnostics, field by field. Contact details are held but never shown.

The company

Name
Optina Diagnostics
Type
For profit
Status
Private
Founded
2011
Founders
Chantal Miklosi, David Lapointe
Industry
Medical Device
Categories
Biotechnology, Medical Device
Specialities
Alzheimer's Disease, Retinal Imaging, Medical Devices, Diagnostic Imaging, Phenotyping, Artificial Intelligence, Diseases of the eye

Where

City
Montréal
Region
QC
Country
Canada

Size and reach

Staff band
11-50
People on LinkedIn
27
LinkedIn followers
4,865
Web traffic rank
#3,786,763
Monthly web visits
3,147

Funding, as listed

Total
$25,248,045 USD
Rounds
5
Latest round
Series a
Latest round date
Jan 2022
Latest amount
2,100,000 USD
Investors
17
Lead investors
4
Listing status
private

About this record

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Optina Diagnostics may be growing as indicated by the recent FDA clearance of its ophthalmic camera, which is a significant regulatory milestone that can lead to increased market access and potential sales growth. Furthermore, the mention of Optina Diagnostics alongside other companies in the context of growth investing suggests that it is being recognized in the investment community, which could correlate with financial growth or the potential for future investments. Additionally, the personal fees received by an individual from Optina Diagnostics outside of submitted work imply that the company has financial resources to engage experts, which can be a sign of operational investment and growth.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

Medical Device in Canada.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.